Rossari Biotech Limited — Board Meeting, 25-04-2025: Outcome of Board Meeting

The Board of Directors has approved the audited financial results for the quarter and financial year ended March 31, 2025, and declared a final dividend of ₹0.50 per share, subject to shareholder approval at the upcoming AGM. The board also appointed M/s. Shah Patel & Associates as the Secretarial Auditor for five consecutive years from FY 2025-26 and approved the grant of 834,250 stock options under the Rossari Employee Stock Option Plan - 2019. Additionally, the board discussed capacity expansion with an expected investment of ₹95 crore, aiming to enhance competitiveness and meet market demand.